Neuroepidemiology. 2019;52(3):161-172. doi: 10.1159/000494291. Epub 2019 Jan 22.
Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.
Neuroepidemiology
Merel C Broers, Carina Bunschoten, Daan Nieboer, Hester F Lingsma, Bart C Jacobs
Affiliations
Affiliations
- Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands, [email protected].
- Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
PMID: 30669140
PMCID: PMC6518865 DOI: 10.1159/000494291
Abstract
BACKGROUND: Prevalence and incidence rates of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are required to determine the impact of CIDP on society. We aimed to estimate the prevalence and incidence of CIDP worldwide and to determine the effect of diagnostic criteria on prevalence and incidence.
METHOD: A systematic review was conducted for all published incidence and prevalence studies on CIDP until May 18, 2017. Methodological quality was assessed using the Methodological Evaluation of Observational Research checklist. We performed a random effect meta-analysis to estimate pooled prevalence and incidence rates.
RESULTS: Of the 907 studies, 11 were included in the systematic review, 5 in the meta-analysis of incidence (818 cases; 220,513,514 person-years) and 9 in the meta-analysis of prevalence (3,160 cases; 160,765,325 population). These studies had a moderate quality. The pooled crude incidence rate was 0.33 per 100,000 person-years (95% CI 0.21-0.53; I2 = 95.7%) and the pooled prevalence rate was 2.81 per 100,000 (95% CI 1.58-4.39; I2 = 99.1%). Substantial heterogeneity in incidence and prevalence across studies seems to be partly explained by using different diagnostic criteria.
CONCLUSION: These findings provide a starting point to estimate the social burden of CIDP and demonstrate the need to reach consensus on diagnostic criteria for CIDP.
© 2019 The Author(s) Published by S. Karger AG, Basel.
Keywords: Chronic inflammatory demyelinating polyradiculoneuropathy; Incidence; Meta-analysis; Prevalence; Systematic review
References
- J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1364-8 - PubMed
- Neurology. 2007 May 8;68(19):1622-9 - PubMed
- Muscle Nerve. 2011 Jun;43(6):780-94 - PubMed
- Neurology. 2010 Aug 31;75(9):818-25 - PubMed
- Ann Neurol. 1999 Dec;46(6):910-3 - PubMed
- JAMA Neurol. 2017 Oct 1;74(10):1190-1198 - PubMed
- N Engl J Med. 2005 Mar 31;352(13):1343-56 - PubMed
- Eur Neurol. 2016;75(5-6):263-8 - PubMed
- J Diabetes Complications. 2016 Sep-Oct;30(7):1401-7 - PubMed
- J Peripher Nerv Syst. 2014 Mar;19(1):2-13 - PubMed
- J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1349-53 - PubMed
- J Neurol Sci. 2016 Oct 15;369:204-209 - PubMed
- Rheumatology (Oxford). 2017 Nov 1;56(11):1945-1961 - PubMed
- Eur J Epidemiol. 2016 Jan;31(1):5-20 - PubMed
- PLoS One. 2012;7(10):e48078 - PubMed
- Muscle Nerve. 2014 Jul;50(1):47-51 - PubMed
- J Clin Endocrinol Metab. 2016 Jul;101(7):2826-35 - PubMed
- J Orofac Pain. 2013 Spring;27(2):99-110 - PubMed
- Eur J Neurol. 2014;21(1):28-33 - PubMed
- J Neurol Neurosurg Psychiatry. 1999 May;66(5):677-80 - PubMed
- J Neurotrauma. 2018 Dec 19;: - PubMed
- Clin Epidemiol. 2014 Jul 30;6:247-55 - PubMed
- J Peripher Nerv Syst. 2010 Dec;15(4):326-33 - PubMed
- J Neuromuscul Dis. 2017;4(2):127-137 - PubMed
- Neurology. 2015 Jan 20;84(3):259-64 - PubMed
- Eur J Neurol. 2006 Apr;13(4):326-32 - PubMed
- J Oral Rehabil. 2013 Aug;40(8):631-42 - PubMed
- J Clin Epidemiol. 2011 Jun;64(6):637-57 - PubMed
- Eur J Neurol. 2007 Jun;14(6):603-8 - PubMed
- Muscle Nerve. 2014 Jul;50(1):40-6 - PubMed
- J Peripher Nerv Syst. 2010 Mar;15(1):1-9 - PubMed
- Ann Neurol. 2001 Aug;50(2):195-201 - PubMed
- Neurology. 1991 May;41(5):617-8 - PubMed
- Neurology. 2003 Apr 1;60(8 Suppl 3):S8-15 - PubMed
- Muscle Nerve. 2009 Apr;39(4):432-8 - PubMed
- Neurology. 2009 Jul 7;73(1):39-45 - PubMed
- Neurology. 1997 Feb;48(2):321-8 - PubMed
- Cochrane Database Syst Rev. 2017 Jan 13;1:CD010369 - PubMed
- Neuroepidemiology. 2011;36(2):123-33 - PubMed
- J Peripher Nerv Syst. 2009 Dec;14(4):310-5 - PubMed
- Brain. 1987 Dec;110 ( Pt 6):1617-30 - PubMed
- PLoS One. 2013 Jun 19;8(6):e66435 - PubMed
- Lancet Neurol. 2010 Apr;9(4):402-12 - PubMed
- Mayo Clin Proc. 1975 Nov;50(11):621-37 - PubMed
- J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1118-1119 - PubMed
- Ann Rheum Dis. 2015 Jan;74(1):65-73 - PubMed
- Neuromuscul Disord. 2016 Jul;26(7):447-52 - PubMed
- Neurology. 2017 Jan 17;88(3):304-313 - PubMed
- J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1040-3 - PubMed
- Muscle Nerve. 1989 Jun;12(6):435-51 - PubMed
- J Neuromuscul Dis. 2015;2(1):73-85 - PubMed
- Muscle Nerve. 2001 Mar;24(3):311-24 - PubMed
- Lancet. 2016 Aug 13;388(10045):717-27 - PubMed
- Nat Rev Neurol. 2011 Nov 22;8(1):48-58 - PubMed
- Neurol Res. 2012 Dec;34(10):960-6 - PubMed
- Eur J Neurol. 2001 Mar;8(2):157-65 - PubMed
- Psychiatry Clin Neurosci. 1995 Jun;49(3):169-74 - PubMed
MeSH terms
Publication Types